MU scientists 'see' how HIV matures into an infection

October 02, 2008

Researchers have speculated about the process, but never known until now

COLUMBIA, Mo. - After improving the sensitivity of nuclear magnetic resonance (NMR), researchers at the University of Missouri actually watched the HIV-1 protease mature from an inactive form into an active infection. This process has never been directly visualized before. The findings appear today in the journal Nature.

"We actually saw the process occur," said Chun Tang, assistant professor of biochemistry in the MU School of Medicine. "This is something that has never been done before. We now understand more about the maturation process. We hope this will be a stepping stone to intervening before the infection progresses."

The HIV-1 protease is responsible for releasing the essential building blocks of an infective HIV-1 viral particle, the culprit of AIDS. The HIV-1 protease is one of the primary targets of therapeutic treatment. However, the viral enzyme is constantly mutating in an effort to gain drug resistance.

"HIV-1 protease is not an active enzyme when it is first expressed in cells. It has to be activated to do its job," Tang said. "What we were able to see is how it self-activates from an immature form when the virus is not infective into a mature form when the virus gains infectivity."

Tang and his colleagues used a novel NMR method called paramagnetic resonance relaxation enhancement and were able to see the temporary joining of two halves of HIV-1 protease precursor, something that had not been accessible before using conventional techniques.

The researchers discovered that the 'tail,' or the flanking amino acid residues, of the HIV-1 protease precursor go through a temporarily formed tunnel where the tail is cut off. At this point, the protease becomes active, the maturation process proceeds, and the virus becomes infective.

"The more we understand about the virus, especially about the maturation into infection, the more we can do to identify novel therapeutics," Tang said.

University of Missouri-Columbia

Isolation of adenosine, iso-sinensetin and dimethylguanosine with antioxidant and HIV-1 protease inhibiting activities from fruiting bodies of ... Journal of Phytotherapy & Phytopharmacology
by Y. Jiang (Author), J.H. Wong (Author), M. Fu (Author), T.B. Ng (Author), Z.K. Liu (Author), C.R. Wang (Author), N. Li (Author), W.T. Qiao (Author), T.Y. Wen (Author), F. Liu (Author)

This digital document is an article from Phytomedicine: International Journal of Phytotherapy & Phytopharmacology, published by Urban & Fischer Verlag on January 15, 2011. The length of the article is 4800 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: Isolation of adenosine, iso-sinensetin and dimethylguanosine with antioxidant and HIV-1 protease inhibiting activities from fruiting bodies of Cordyceps militaris.(Report)
Author: Y. Jiang
Publication: Phytomedicine: International Journal of Phytotherapy & Phytopharmacology (Magazine/Journal)
Date: January 15, 2011
Publisher: Urban & Fischer...

Designing New Antiviral Drugs for AIDS: HIV-1 Protease and Its Inhibitors (Bioscience Reports (Austin, Tex.).)
by Darren March (Author), David P. Fairlie (Author)

Insilico analysis of Docking between HIV-1 PR and derivatives of CUI: Docking between HIV-1 proteases and cyclic urea inhibitors : A step towards drug designing against AIDS
by Dhruv Kumar (Author)

HIV-1 Proteases (PR) are an enzyme which cleaves the long HIV polyprotein into small functional peptide fragment. These small fragments again terminate into mature HIV. Inhibition of cleavage of poly protein into small peptide fragment could prevent regeneration of HIV. Computational docking between HIV-1 PR and derivatives of Cyclic Urea Inhibitors (CUIs) has provide us clue to design drug against AIDS. Computational approaches were used to dock ligand (CUIs) with HIV-1 PR to stop cleavage. CUIs are seven-member ring structure of cyclic urea compound. It incorporates the hydrogen-bonding equivalents of an enzyme-bound water molecule into a low molecular weight. Our result suggest that some of derivatives of CUIs binds with HIV-1 PR, which can be stop the fuction of HIV-1...

Structural-Aided Design of Antiviral Drugs: Application of the Method of HIV-1 Protease and Siv Reverse Transcriptase (Comprehensive Summaries of ... from the Faculty of Science & Technology)
by Hans Ola Andersson (Author)

Cyclic Sulfamides As HIV-1 Protease Inhibitors: Synthesis, X-Ray Structure Analysis and Structure-Activity Relationship (Comprehensive Summaries of ... from the Faculty of Pharmacy, 213)
by Johan Hulten (Author)

medEssentials for the USMLE Step 1 (Kaplan Medessenitals for the USMLE Step 1)
by Michael S. Manley (Author), Leslie D. Manley (Author)

medEssentials for the USMLE Step 1 offers a thorough review of early medical school curriculum and the highest-yield prep for the USMLE. Ranked at âAâ level by First Aid for the USMLE Step 1, this book is an ideal textbook companion for first- and second-year medical students.Structured by organ system, medEssentials for the USMLE Step 1 packs multiple disciplines into one manual and reviews the core science concepts covered in medical programs and on the USMLE. Eight different online exercises feature a personalized learning matrix that provides a visual snapshot of a studentâs strengths and weaknesses. A 12-page, full-color insert of medical photography illustrates the most tested concepts and diseases.

Studies of the translational entropy contribution to protein stability by use of the HIV-1 protease as a model system.
by Erik Antonio Billings (Author)

In the quest to predict the Gibbs energy of protein stability, the magnitude of the translational entropy contribution to the stability of 2-state oligomeric proteins has yet to be agreed upon by any meaningful consensus of the various research groups engaged in the task. In an effort to resolve the ongoing dispute, the work herein describes the use of the HIV-1 protease as a model system with which to quantitatively compare and contrast the translational entropy contribution predicted by the cratic and Sackur-Tetrode methodologies versus the experimentally observed value. Toward this end, Differential Scanning Calorimetry was used to measure the stability of wild-type dimeric HIV-1 protease and a series of tethered HIV-1 proteases. The difference in stability and total entropy of...

Protease Inhibitors in AIDS Therapy (Infectious Disease and Therapy)
by Richard C. Ogden (Author), Charles Flexner (Author)

Details the evolution of HIV protease inhibitors from molecular development through medical applications! Considering the latest class of revolutionary drugs fighting against HIV infection and AIDS, this comprehensive reference thoroughly examines the development and properties of HIV protease inhibitors from clinical and scientific perspectives, discussing how protease inhibitors changed the FDA approval process-enhancing the collaboration between regulatory authorities and drug developers. Spotlights protease inhibitors as the cornerstone drugs of the first HAART regimens-key components of long-term viral suppression and immune restoration, and in secondary and tertiary regimens! Evaluating protease inhibitors as therapeutic options and research tools, Protease Inhibitors in...

Psychosocial and Public Health Impacts of New HIV Therapies (Aids Prevention and Mental Health)
by David G. Ostrow (Editor), Seth C. Kalichman (Editor), Nicoli Nattrass (Editor)

This volume addresses the issues surrounding combination drug therapies and the treatment of HIV/AIDS. Each chapter, written by a leading researcher, provides the latest information on the pharmacology, clinical use - including adherence to treatment guidelines - prevention implications, mental health ramifications, and ethical and policy issues. By highlighting context as well as content, and focusing on general principles in addition to specific details, this necessary text remains relevant and valuable for future treatment advances.

Lipodystrophhy Syndrome in HIV
by Christine A. Wanke (Editor), Sherwood L. Gorbach (Editor)

The evolution of data about the HIV-Associated Lipodystrophy Syndrome has been rapid. The syndrome itself is complex and controversial. Although great progress has been made in understanding epidemiology and etiology of the syndrome, much about the syndrome remains mysterious. Each author of Lipodystrophy Syndrome in HIV was requested to provide an evidence-based discussion of a topic for which they have expertise. The approach of this volume allows the reader to develop a relatively complete snapshot of the syndrome and confront the emerging literature on the HIV-associated lipodystrophy syndrome with a critical eye.